OABI

OmniAb, Inc.

Nasdaq· Services-Commercial Physical & Biological Research· Inc. DE· CIK 0001846253 Biotech & Drug Discovery

$4.66 −0.12 (−2.51%)

Oct 23 4:00 PM ET · prev $4.78

Market cap

$695.0M

Small cap

Consensus

Buy

92% Buy or better · 13 analysts

Median target

$8.00

+72% · range $5.00–12.00

Next earnings

Oct 30

in 4 days · EPS est. −$0.13

1 year

+193.1%

from $1.59 · Oct 27

30 days

−1.7%

from $4.74

52-week range

$1.36–5.04

−8% from high · low Apr 29

Avg volume 20D

1.39M

shares / day

Short interest

🔒 Subscribers only

Insider net

−$108.4K

0 buyers · 3 sellers · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read MIXED 1 report · latest

Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score

Avg score

·High conf. 1/1 ·Next Earnings date, Oct 30, 2026

Strongest NEUTRAL Two C-suite executives at OmniAb — the CFO and Chief Legal Officer — each sold a small number of shares in…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

S Feb 17 3 insiders sell $58.8K at $1.70
S Apr 7 3 insiders sell $49.6K at $1.49

Signal stack

Where each data set points today.

InsidersBEARISH

3 insiders sold $108.4K.
InstitutionsBULLISH

Q2 2026: 17 added (0 new), 5 trimmed or exited.
AnalystsBULLISH

12 of 13 rate it Buy or better. Every target is above the price.
EstimatesFALLING

Current-quarter EPS estimate −$0.117 → −$0.130 over 90 days. 1 up, 3 down in 30 days.
TrendUPTREND

3% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
NOMURA HOLDINGS INC	DOUBLED	5,028,160	$12.4M
DIMENSIONAL FUND ADVISORS LP	TRIM	1,262,099	$3.1M
RENAISSANCE TECHNOLOGIES LLC	DOUBLED	600,350	$1.5M
D. E. Shaw & Co., Inc.	ADD	559,404	$1.4M
WELLS FARGO & COMPANY/MN	ADD	100,229	$246.6K
AMERICAN CENTURY COMPANIES INC	DOUBLED	75,083	$184.7K
Connor, Clark & Lunn Investment Management Ltd.	DOUBLED	72,357	$178.0K
MetLife Investment Management, LLC	ADD	65,744	$161.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts

Buy 92% rate it Buy or better

Strong Buy4Buy8Hold1Sell0Strong Sell0

12-month targets · 6 analysts

$4.66 $5.00 $8.00 $12.00

Price is below the lowest target. Median implies +72%.Targets as of Oct 27, 2026.

Recent actions

Date	Firm	Action	Rating
Oct 7, 2026	Leerink Partners MAINTAIN	MAINTAIN	Outperform
Oct 7, 2026	StoneX MAINTAIN	MAINTAIN	Buy
Aug 17, 2026	HC Wainwright & Co. REITERATE	REITERATE	Buy

Insider ledger

Form 4

bought · 0 insiders

$108.4K

sold · 3 insiders

Date	Insider	Type	Value
Aug 1, 2026	Nwachuku Amechi Ekeke Chief Operating Officer	AWARD	800,000 sh
Jun 17, 2026	HIGGINS JOHN L Director	EXERCISE	20,000 sh
Jun 17, 2026	HIGGINS JOHN L Director	AWARD	20,000 sh
Jun 17, 2026	HIGGINS JOHN L Director	AWARD	40,000 sh
Jun 17, 2026	Love Steven Director	AWARD	40,000 sh
Jun 17, 2026	Gotwals Philip J Director	AWARD	20,000 sh
Jun 17, 2026	Gotwals Philip J Director	AWARD	40,000 sh
Jun 17, 2026	Love Steven Director	EXERCISE	20,000 sh

Earnings setup

Estimates

Oct 30

reports in 4 days

−$0.13

EPS estimate, this quarter

−11%

estimate change, 90 days

1↑ 3↓

revisions, 30 days

Current-quarter EPS estimate

−$0.117

90d

−$0.133

60d

−$0.130

30d

−$0.130

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.13	-$0.14–-$0.12	+0.0%	$3.5M
Next Q	-$0.14	-$0.15–-$0.12	+0.0%	$3.8M
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only